FDA Sarclisa Approval Marks Sanofi's Reentry Into Oncology

Milestone on Road
Sanofi reached a milestone getting a new cancer drug to market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip